FIELD: medicine, pharmacy. SUBSTANCE: composition has 12-30 mg/ml of cyclosporin A or budesonide and 130-375 mg/ml of phospholipid in superpure water. Composition is placed into sprayer capacity. The second variant of composition: about 21.3 mg/ml of cyclosporin A and up to 160 mg/ml of dilaurylphospha-tidylcholine of initial concentration in sprayer. The third variant: up to 12.5 mg/ml of budesonide and up to about 187.5 mg/ml of dilauroylphosphatidylcholine of initial concentration in sprayer. The range of liposome particles as measured by aerodynamic diameter of median mass is from about 1.0 mcm to about 3.0 mcm. Invention ensures to prepare the concentrated compositions with high doses of active substances that provides maximal productivity of aerosol preparation based on thereof. Invention can be used in medicine for treatment of patients with different pulmonary diseases. EFFECT: improved properties of compositions. 16 cl, 13 dwg, 1 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
IMPROVEMENT INHALATION THERAPY EFFECTIVENESS USING CARBON DIOXIDE | 2000 |
|
RU2270683C2 |
STABILIZATION OF COMPOSITIONS "LIPID : DNA" IN SPRAYING PROCESS | 1999 |
|
RU2213578C2 |
LIPOSOME AEROSOLS WITH SMALL-SIZE PARTICLES FOR TRANSPORTING ANTICANCER THERAPEUTIC PREPARATIONS | 1998 |
|
RU2223749C2 |
INCREASED GENIC EXPRESSION DUE TO GLUCOCORTICOIDS | 1996 |
|
RU2203093C2 |
COMPOSITIONS POLYETHYLENEIMINE : DNA FOR AEROSOL DELIVERY | 2000 |
|
RU2242970C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINE | 2006 |
|
RU2421209C2 |
SYSTEMS FOR TREATMENT OF PULMONARY INFECTIONS | 2013 |
|
RU2657510C2 |
LIPOSOME DELIVERY OF COMPOSITIONS BASED ON VITAMIN E | 2002 |
|
RU2328273C2 |
LIPOSOMES RENDERING THYMUS-DEPENDENT ASSISTANCE TO "WEAK" ANTIGENS USED FOR PREPARING VACCINE | 1993 |
|
RU2107493C1 |
ADVANCED WOUND COVER FOR IMPROVING WOUND HEALING | 2000 |
|
RU2245722C2 |
Authors
Dates
2001-10-10—Published
1997-07-02—Filed